Andermann syndrome: Difference between revisions
CSV import |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | {{Infobox medical condition | ||
| name = Andermann syndrome | | name = Andermann syndrome | ||
| synonyms = Agenesis of corpus callosum with peripheral neuropathy | | synonyms = Agenesis of corpus callosum with peripheral neuropathy | ||
| specialty = [[Neurology]] | | specialty = [[Neurology]] | ||
Revision as of 17:21, 27 December 2024
| Andermann syndrome | |
|---|---|
| Synonyms | Agenesis of corpus callosum with peripheral neuropathy |
| Pronounce | N/A |
| Specialty | Neurology |
| Symptoms | Developmental delay, intellectual disability, seizures, hypotonia, peripheral neuropathy |
| Complications | N/A |
| Onset | Infancy |
| Duration | Lifelong |
| Types | N/A |
| Causes | Genetic mutation in the SLC12A6 gene |
| Risks | Genetic inheritance |
| Diagnosis | Genetic testing, MRI |
| Differential diagnosis | N/A |
| Prevention | N/A |
| Treatment | Supportive care, physical therapy, occupational therapy |
| Medication | N/A |
| Prognosis | Variable |
| Frequency | Rare |
| Deaths | N/A |
Andermann syndrome, also known as agenesis of corpus callosum with peripheral neuropathy, is a rare genetic disorder characterized by the absence or malformation of the corpus callosum and peripheral neuropathy. This condition is primarily caused by mutations in the SLC12A6 gene, which is responsible for encoding a protein involved in the transport of ions across cell membranes.
Signs and Symptoms
Individuals with Andermann syndrome typically present with a range of neurological symptoms, including:
- Developmental delay
- Intellectual disability
- Seizures
- Hypotonia (reduced muscle tone)
- Peripheral neuropathy, which may lead to muscle weakness and sensory loss
Causes
Andermann syndrome is caused by mutations in the SLC12A6 gene, which is located on chromosome 15. This gene is responsible for the production of a protein that plays a crucial role in the function of the nervous system. The disorder is inherited in an autosomal recessive manner, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent.
Diagnosis
Diagnosis of Andermann syndrome is typically based on clinical evaluation, genetic testing, and neuroimaging studies such as MRI to assess the structure of the brain.
Treatment
There is currently no cure for Andermann syndrome, and treatment is primarily supportive. Management strategies may include:
- Physical therapy to improve motor skills
- Occupational therapy to assist with daily activities
- Seizure management with anticonvulsant medications
Prognosis
The prognosis for individuals with Andermann syndrome varies depending on the severity of symptoms. Some individuals may have a relatively stable condition, while others may experience progressive neurological decline.
Epidemiology
Andermann syndrome is a rare disorder, with a higher prevalence reported in certain populations, such as the French-Canadian population in the Saguenay–Lac-Saint-Jean region of Quebec, Canada.